Antagonistic effect of picolinic acid and interferon-gamma on macrophage inflammatory protein-1alpha/beta production

Annamaria Rapisarda1, Sandra Pastorino, Stefano Massazza

  • 1Laboratory of Molecular Biology, G. Gaslini Institute, 16147, Genoa, Italy.

Cellular Immunology
|April 30, 2003
PubMed

Insights

Picolinic acid (PA) activates macrophages, but the Th1 cytokine IFN-gamma downregulates this response. This study reveals how IFN-gamma inhibits macrophage inflammatory protein (MIP) production, crucial for immune regulation.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Picolinic acid (PA), an L-tryptophan catabolite, activates macrophage functions and induces macrophage inflammatory proteins (MIPs).
  • Understanding the regulation of MIPs production is crucial for controlling inflammatory responses.

Purpose of the Study:

  • To investigate the regulatory mechanisms of PA-induced MIPs production in mouse macrophages.
  • To elucidate the specific role of IFN-gamma in modulating MIPs expression.

Main Methods:

  • Primary mouse macrophages were treated with PA and/or IFN-gamma.
  • mRNA expression levels of MIPs were quantified using RT-PCR.
  • Intracellular and secreted chemokine levels were measured.
  • Effects on mRNA stability and gene transcription were assessed.

Main Results:

  • IFN-gamma dose- and time-dependently downregulated MIPs mRNA and protein production.
  • This inhibitory effect was specific to IFN-gamma and not observed with Th2 cytokines (IL-10, IL-4) or LPS.
  • IFN-gamma-mediated downregulation involved both mRNA destabilization and inhibition of gene transcription.
  • PA and IFN-gamma exhibited antagonistic effects on MIPs production.

Conclusions:

  • Macrophage MIP-1alpha/beta production is tightly regulated by the interplay between immune system-derived inhibitory signals (like IFN-gamma) and non-immunologic stimulatory signals (like PA).
  • The antagonistic interaction between PA and IFN-gamma is significant for regulating in vivo inflammatory responses.